|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 |
| (11) | Number of the document | 3193919 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15842660.1 |
| Date of filing the European patent application | 2015-09-15 | |
| (97) | Date of publication of the European application | 2017-07-26 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/050270 |
| Date | 2015-09-15 |
| (87) | Number | WO 2016/044326 |
| Date | 2016-03-24 |
| (30) | Number | Date | Country code |
| 201462050567 P | 2014-09-15 | US |
| (72) |
YU, Cheng-der Tony, TW
HSIEH, Yih Huang, TW
CHEN, I Ju, TW
LEE, Wei-han, TW
WANG, Nan-hsuan, TW
|
| (73) |
OBI Pharma, Inc.,
Room W1907, 19F, 3 Yuan-Qu Street Nanking District, Tapei City, 11503,
TW
|
| (54) | IMMUNOGENIC/THERAPEUTIC GLYCOCONJUGATE COMPOSITIONS AND USES THEREOF |
| IMMUNOGENIC/THERAPEUTIC GLYCOCONJUGATE COMPOSITIONS AND USES THEREOF |